APO Research
Talk to an analyst

APO RESEARCH · REPORT

Knee Osteoarthritis Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Knee Osteoarthritis Treatment Market Outlook and Growth Opportunities 2026

20 December 2025192 pages

Choose your research edition.

Industry ResearchKnee Osteoarthritis Treatment Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Knee Osteoarthritis Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Knee Osteoarthritis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Knee Osteoarthritis Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Knee Osteoarthritis Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Knee Osteoarthritis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Knee Osteoarthritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Knee Osteoarthritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Knee Osteoarthritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Knee Osteoarthritis Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Knee Osteoarthritis Treatment market include Anika Therapeutics, AVM Biotechnology, Bioventus, Flexion Therapeutics, Horizon Therapeutics, OrthoTrophix, Bayer, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Knee Osteoarthritis Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Knee Osteoarthritis Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Knee Osteoarthritis Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Knee Osteoarthritis Treatment market.

Knee Osteoarthritis Treatment Segment by Company

Anika Therapeutics

AVM Biotechnology

Bioventus

Flexion Therapeutics

Horizon Therapeutics

OrthoTrophix

Bayer

GlaxoSmithKline

Pfizer

Eli Lilly

Johnson and Johnson

Sanofi

Abbott

Knee Osteoarthritis Treatment Segment by Type

Non-surgical Treatment

Surgical Treatment

Knee Osteoarthritis Treatment Segment by Application

Ambulatory Surgical Centers

Hospitals

Specialty Clinics

Others

Knee Osteoarthritis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Knee Osteoarthritis Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Knee Osteoarthritis Treatment key companies, revenue, market share, and recent developments.

3. To split the Knee Osteoarthritis Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Knee Osteoarthritis Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Knee Osteoarthritis Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Knee Osteoarthritis Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Knee Osteoarthritis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Knee Osteoarthritis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Knee Osteoarthritis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Knee Osteoarthritis Treatment industry.

Chapter 3: Detailed analysis of Knee Osteoarthritis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Knee Osteoarthritis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Knee Osteoarthritis Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Knee Osteoarthritis Treatment Industry Trends Table 2. Knee Osteoarthritis Treatment Industry Drivers Table 3. Knee Osteoarthritis Treatment Industry Opportunities and Challenges Table 4. Knee Osteoarthritis Treatment Industry Restraints Table 5. Global Knee Osteoarthritis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Knee Osteoarthritis Treatment Revenue Share by Company (2021-2026) Table 7. Global Knee Osteoarthritis Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Knee Osteoarthritis Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Knee Osteoarthritis Treatment Company, Product Type & Application Table 10. Global Knee Osteoarthritis Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Knee Osteoarthritis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Non-surgical Treatment Table 15. Significant Companies of Surgical Treatment Table 16. Global Knee Osteoarthritis Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Knee Osteoarthritis Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Knee Osteoarthritis Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Knee Osteoarthritis Treatment Sales Value Share by Type (2021-2026) Table 20. Global Knee Osteoarthritis Treatment Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Ambulatory Surgical Centers Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Specialty Clinics Table 24. Significant Companies of Others Table 25. Global Knee Osteoarthritis Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Knee Osteoarthritis Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Knee Osteoarthritis Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Knee Osteoarthritis Treatment Sales Value Share by Application (2021-2026) Table 29. Global Knee Osteoarthritis Treatment Sales Value Share by Application (2027-2032) Table 30. Global Knee Osteoarthritis Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Knee Osteoarthritis Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Knee Osteoarthritis Treatment Sales Value Share by Region (2021-2026) Table 33. Global Knee Osteoarthritis Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Knee Osteoarthritis Treatment Sales Value Share by Region (2027-2032) Table 35. Global Knee Osteoarthritis Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Knee Osteoarthritis Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Knee Osteoarthritis Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Knee Osteoarthritis Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Knee Osteoarthritis Treatment Sales Value Market Share by Country (2027-2032) Table 40. Anika Therapeutics Company Information Table 41. Anika Therapeutics Business Overview Table 42. Anika Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Anika Therapeutics Knee Osteoarthritis Treatment Product Portfolio Table 44. Anika Therapeutics Recent Development Table 45. AVM Biotechnology Company Information Table 46. AVM Biotechnology Business Overview Table 47. AVM Biotechnology Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. AVM Biotechnology Knee Osteoarthritis Treatment Product Portfolio Table 49. AVM Biotechnology Recent Development Table 50. Bioventus Company Information Table 51. Bioventus Business Overview Table 52. Bioventus Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Bioventus Knee Osteoarthritis Treatment Product Portfolio Table 54. Bioventus Recent Development Table 55. Flexion Therapeutics Company Information Table 56. Flexion Therapeutics Business Overview Table 57. Flexion Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Flexion Therapeutics Knee Osteoarthritis Treatment Product Portfolio Table 59. Flexion Therapeutics Recent Development Table 60. Horizon Therapeutics Company Information Table 61. Horizon Therapeutics Business Overview Table 62. Horizon Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Horizon Therapeutics Knee Osteoarthritis Treatment Product Portfolio Table 64. Horizon Therapeutics Recent Development Table 65. OrthoTrophix Company Information Table 66. OrthoTrophix Business Overview Table 67. OrthoTrophix Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. OrthoTrophix Knee Osteoarthritis Treatment Product Portfolio Table 69. OrthoTrophix Recent Development Table 70. Bayer Company Information Table 71. Bayer Business Overview Table 72. Bayer Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Bayer Knee Osteoarthritis Treatment Product Portfolio Table 74. Bayer Recent Development Table 75. GlaxoSmithKline Company Information Table 76. GlaxoSmithKline Business Overview Table 77. GlaxoSmithKline Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GlaxoSmithKline Knee Osteoarthritis Treatment Product Portfolio Table 79. GlaxoSmithKline Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Pfizer Knee Osteoarthritis Treatment Product Portfolio Table 84. Pfizer Recent Development Table 85. Eli Lilly Company Information Table 86. Eli Lilly Business Overview Table 87. Eli Lilly Knee Osteoarthritis Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Eli Lilly Knee Osteoarthritis Treatment Product Portfolio Table 89. Eli Lilly Recent Development Table 90. Johnson and Johnson Company Information Table 91. Johnson and Johnson Business Overview Table 92. Johnson and Johnson Knee Osteoarthritis Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Johnson and Johnson Knee Osteoarthritis Treatment Product Portfolio Table 94. Johnson and Johnson Recent Development Table 95. Sanofi Company Information Table 96. Sanofi Business Overview Table 97. Sanofi Knee Osteoarthritis Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Sanofi Knee Osteoarthritis Treatment Product Portfolio Table 99. Sanofi Recent Development Table 100. Abbott Company Information Table 101. Abbott Business Overview Table 102. Abbott Knee Osteoarthritis Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Abbott Knee Osteoarthritis Treatment Product Portfolio Table 104. Abbott Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Knee Osteoarthritis Treatment Product Image Figure 2. Global Knee Osteoarthritis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Knee Osteoarthritis Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Knee Osteoarthritis Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Non-surgical Treatment Image Figure 8. Surgical Treatment Image Figure 9. Global Knee Osteoarthritis Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Knee Osteoarthritis Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Knee Osteoarthritis Treatment Sales Value Share by Type (2021-2032) Figure 12. Ambulatory Surgical Centers Image Figure 13. Hospitals Image Figure 14. Specialty Clinics Image Figure 15. Others Image Figure 16. Global Knee Osteoarthritis Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Knee Osteoarthritis Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Knee Osteoarthritis Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Knee Osteoarthritis Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Knee Osteoarthritis Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Knee Osteoarthritis Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Knee Osteoarthritis Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Knee Osteoarthritis Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Knee Osteoarthritis Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Knee Osteoarthritis Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Knee Osteoarthritis Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Knee Osteoarthritis Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Knee Osteoarthritis Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Knee Osteoarthritis Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Knee Osteoarthritis Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Non-surgical Treatment
  • Surgical Treatment
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics
  • Others
Companies covered
  • Anika Therapeutics
  • AVM Biotechnology
  • Bioventus
  • Flexion Therapeutics
  • Horizon Therapeutics
  • OrthoTrophix
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Johnson and Johnson
  • Sanofi
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Knee Osteoarthritis Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Knee Osteoarthritis Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Knee Osteoarthritis Treatment Market Dynamics
  1. 2.1 Knee Osteoarthritis Treatment Industry Trends
  2. 2.2 Knee Osteoarthritis Treatment Industry Drivers
  3. 2.3 Knee Osteoarthritis Treatment Industry Opportunities and Challenges
  4. 2.4 Knee Osteoarthritis Treatment Industry Restraints
3 Knee Osteoarthritis Treatment Market by Company
  1. 3.1 Global Knee Osteoarthritis Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Knee Osteoarthritis Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Knee Osteoarthritis Treatment Company Ranking (2024-2026)
  4. 3.4 Global Knee Osteoarthritis Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Knee Osteoarthritis Treatment Company Product Type and Application
  6. 3.6 Global Knee Osteoarthritis Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Knee Osteoarthritis Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Knee Osteoarthritis Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Knee Osteoarthritis Treatment Market by Type
  1. 4.1 Knee Osteoarthritis Treatment Type Introduction
  2. 4.1.1 Non-surgical Treatment
  3. 4.1.2 Surgical Treatment
  4. 4.2 Global Knee Osteoarthritis Treatment Sales Value by Type
  5. 4.2.1 Global Knee Osteoarthritis Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Knee Osteoarthritis Treatment Sales Value by Type (2021-2032)
  7. 4.2.3 Global Knee Osteoarthritis Treatment Sales Value Share by Type (2021-2032)
5 Knee Osteoarthritis Treatment Market by Application
  1. 5.1 Knee Osteoarthritis Treatment Application Introduction
  2. 5.1.1 Ambulatory Surgical Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Specialty Clinics
  5. 5.1.4 Others
  6. 5.2 Global Knee Osteoarthritis Treatment Sales Value by Application
  7. 5.2.1 Global Knee Osteoarthritis Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Knee Osteoarthritis Treatment Sales Value by Application (2021-2032)
  9. 5.2.3 Global Knee Osteoarthritis Treatment Sales Value Share by Application (2021-2032)
6 Knee Osteoarthritis Treatment Regional Value Analysis
  1. 6.1 Global Knee Osteoarthritis Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Knee Osteoarthritis Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Knee Osteoarthritis Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Knee Osteoarthritis Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Knee Osteoarthritis Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Knee Osteoarthritis Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Knee Osteoarthritis Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Knee Osteoarthritis Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Knee Osteoarthritis Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Knee Osteoarthritis Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Knee Osteoarthritis Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Knee Osteoarthritis Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Knee Osteoarthritis Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Knee Osteoarthritis Treatment Sales Value Share by Country, 2025 VS 2032
7 Knee Osteoarthritis Treatment Country-level Value Analysis
  1. 7.1 Global Knee Osteoarthritis Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Knee Osteoarthritis Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Knee Osteoarthritis Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Knee Osteoarthritis Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Knee Osteoarthritis Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Knee Osteoarthritis Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Knee Osteoarthritis Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Anika Therapeutics
  2. 8.1.1 Anika Therapeutics Company Information
  3. 8.1.2 Anika Therapeutics Business Overview
  4. 8.1.3 Anika Therapeutics Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Anika Therapeutics Knee Osteoarthritis Treatment Product Portfolio
  6. 8.1.5 Anika Therapeutics Recent Developments
  7. 8.2 AVM Biotechnology
  8. 8.2.1 AVM Biotechnology Company Information
  9. 8.2.2 AVM Biotechnology Business Overview
  10. 8.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AVM Biotechnology Knee Osteoarthritis Treatment Product Portfolio
  12. 8.2.5 AVM Biotechnology Recent Developments
  13. 8.3 Bioventus
  14. 8.3.1 Bioventus Company Information
  15. 8.3.2 Bioventus Business Overview
  16. 8.3.3 Bioventus Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bioventus Knee Osteoarthritis Treatment Product Portfolio
  18. 8.3.5 Bioventus Recent Developments
  19. 8.4 Flexion Therapeutics
  20. 8.4.1 Flexion Therapeutics Company Information
  21. 8.4.2 Flexion Therapeutics Business Overview
  22. 8.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Flexion Therapeutics Knee Osteoarthritis Treatment Product Portfolio
  24. 8.4.5 Flexion Therapeutics Recent Developments
  25. 8.5 Horizon Therapeutics
  26. 8.5.1 Horizon Therapeutics Company Information
  27. 8.5.2 Horizon Therapeutics Business Overview
  28. 8.5.3 Horizon Therapeutics Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Horizon Therapeutics Knee Osteoarthritis Treatment Product Portfolio
  30. 8.5.5 Horizon Therapeutics Recent Developments
  31. 8.6 OrthoTrophix
  32. 8.6.1 OrthoTrophix Company Information
  33. 8.6.2 OrthoTrophix Business Overview
  34. 8.6.3 OrthoTrophix Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 OrthoTrophix Knee Osteoarthritis Treatment Product Portfolio
  36. 8.6.5 OrthoTrophix Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Knee Osteoarthritis Treatment Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Knee Osteoarthritis Treatment Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Knee Osteoarthritis Treatment Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Eli Lilly
  56. 8.10.1 Eli Lilly Company Information
  57. 8.10.2 Eli Lilly Business Overview
  58. 8.10.3 Eli Lilly Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Eli Lilly Knee Osteoarthritis Treatment Product Portfolio
  60. 8.10.5 Eli Lilly Recent Developments
  61. 8.11 Johnson and Johnson
  62. 8.11.1 Johnson and Johnson Company Information
  63. 8.11.2 Johnson and Johnson Business Overview
  64. 8.11.3 Johnson and Johnson Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Johnson and Johnson Knee Osteoarthritis Treatment Product Portfolio
  66. 8.11.5 Johnson and Johnson Recent Developments
  67. 8.12 Sanofi
  68. 8.12.1 Sanofi Company Information
  69. 8.12.2 Sanofi Business Overview
  70. 8.12.3 Sanofi Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sanofi Knee Osteoarthritis Treatment Product Portfolio
  72. 8.12.5 Sanofi Recent Developments
  73. 8.13 Abbott
  74. 8.13.1 Abbott Company Information
  75. 8.13.2 Abbott Business Overview
  76. 8.13.3 Abbott Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Abbott Knee Osteoarthritis Treatment Product Portfolio
  78. 8.13.5 Abbott Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst